Nuveen Asset Management Portfolio holdings
Nuveen Asset Management, founded in 1898 by John Nuveen and headquartered in Chicago, Illinois, is a leading global investment manager and subsidiary of TIAA, overseeing hundreds of billions in assets with a focus on fixed income, equities, and sustainable investing. Initially known for municipal bonds, Nuveen has expanded into a broad range of strategies, including mutual funds, ETFs, closed-end funds, and private capital solutions, serving institutional investors, financial advisors, and individuals. The firm emphasizes income-generating investments and ESG (environmental, social, governance) integration, leveraging its deep research capabilities and a century-long legacy in the bond market. With a strong presence in North America and growing international reach, Nuveen blends tradition with innovation to meet diverse client needs in the evolving investment landscape.
Top Buys
| 1 |
Kenvue
KVUE
|
+$503M |
| 2 |
Intel
INTC
|
+$390M |
| 3 |
Zoetis
ZTS
|
+$245M |
| 4 |
Philip Morris
PM
|
+$216M |
| 5 |
Honeywell
HON
|
+$198M |
Top Sells
| 1 |
PepsiCo
PEP
|
+$525M |
| 2 |
RTX Corp
RTX
|
+$357M |
| 3 |
Apple
AAPL
|
+$341M |
| 4 |
Union Pacific
UNP
|
+$292M |
| 5 |
Microsoft
MSFT
|
+$243M |
Sector Composition
| 1 | Technology | 26.55% |
| 2 | Healthcare | 12.07% |
| 3 | Financials | 11.17% |
| 4 | Consumer Discretionary | 10.62% |
| 5 | Industrials | 8.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
2051
TG Therapeutics
TGTX
$5.1B
| $3.19M | ﹤0.01% |
382,110
-2,030
| -0.5% | -$17K |
|
|
ESTE
2052
DELISTED
Earthstone Energy Inc. Class A Common Stock
ESTE
| $3.19M | ﹤0.01% |
+157,406
| New | +$3.19M |
|
2053
Cassava Sciences
SAVA
$102M
| $3.18M | ﹤0.01% |
190,871
-48,852
| -20% | -$813K |
|
2054
Ocular Therapeutix
OCUL
$2.23B
| $3.17M | ﹤0.01% |
1,011,038
+91,436
| +10% | +$287K |
|
2055
Luminar Technologies
LAZR
$129M
| $3.17M | ﹤0.01% |
46,461
-276
| -0.6% | -$18.8K |
|
2056
Lennar Class B
LEN.B
$34B
| $3.16M | ﹤0.01% |
32,553
-10,339
| -24% | -$1M |
|
|
CHS
2057
DELISTED
Chicos FAS, Inc.
CHS
| $3.16M | ﹤0.01% |
422,278
+11,914
| +3% | +$89.1K |
|
|
AVTA
2058
DELISTED
Avantax, Inc. Common Stock
AVTA
| $3.15M | ﹤0.01% |
123,300
-4,823
| -4% | -$123K |
|
2059
Aclaris Therapeutics
ACRS
$211M
| $3.15M | ﹤0.01% |
460,313
+258,896
| +129% | +$1.77M |
|
2060
Kaiser Aluminum
KALU
$1.24B
| $3.15M | ﹤0.01% |
41,849
-56
| -0.1% | -$4.22K |
|
2061
Dell
DELL
$84.1B
| $3.14M | ﹤0.01% |
45,600
| – | – |
|
2062
Pennant Group
PNTG
$884M
| $3.14M | ﹤0.01% |
282,161
-16,130
| -5% | -$180K |
|
2063
IES Holdings
IESC
$7.5B
| $3.14M | ﹤0.01% |
47,626
+9,344
| +24% | +$615K |
|
2064
Viridian Therapeutics
VRDN
$1.54B
| $3.12M | ﹤0.01% |
203,441
-222,754
| -52% | -$3.42M |
|
|
TWO
2065
Two Harbors Investment
TWO
$1.05B
| $3.12M | ﹤0.01% |
235,503
-4,461
| -2% | -$59.1K |
|
2066
PC Connection
CNXN
$1.6B
| $3.12M | ﹤0.01% |
58,369
-8,577
| -13% | -$458K |
|
2067
Rocket Pharmaceuticals
RCKT
$341M
| $3.11M | ﹤0.01% |
151,681
-2,764
| -2% | -$56.6K |
|
2068
ProAssurance
PRA
$1.22B
| $3.11M | ﹤0.01% |
164,516
-1,836
| -1% | -$34.7K |
|
2069
Geron
GERN
$810M
| $3.11M | ﹤0.01% |
1,465,714
+94,739
| +7% | +$201K |
|
|
PMT
2070
PennyMac Mortgage Investment
PMT
$1.07B
| $3.1M | ﹤0.01% |
249,729
-2,789
| -1% | -$34.6K |
|
|
FSR
2071
DELISTED
Fisker Inc.
FSR
| $3.08M | ﹤0.01% |
480,433
+717
| +0.1% | +$4.6K |
|
2072
Catalyst Pharmaceutical
CPRX
$2.44B
| $3.08M | ﹤0.01% |
263,835
+4,631
| +2% | +$54.1K |
|
|
MTTR
2073
DELISTED
Matterport, Inc. Class A Common Stock
MTTR
| $3.06M | ﹤0.01% |
1,408,923
+496,739
| +54% | +$1.08M |
|
2074
Microvision
MVIS
$343M
| $3.05M | ﹤0.01% |
1,394,599
-9,682
| -0.7% | -$21.2K |
|
2075
Levi Strauss
LEVI
$8.67B
| $3.04M | ﹤0.01% |
224,179
-3,202
| -1% | -$43.5K |
|